基于基因共同表达重量网络对与帕金森病相关的关键 lncRNA 的分析
Wenwen Liang1, Wei Zhao1, Binghan Li1
1From the School of Clinical Medicine (Liang, Luo, Jia), Shandong Second Medical University, Weifang, from the Department of Neurology (Liang, Zhao, Lin, Li, Luo, Jia) , Beijing Shijingshan Hospital, Shijingshan Teaching Hospital of Capital Medical University, Beijing, and from the Department of Neurology (Li), Affiliated Hospital of Weifang Medical University, Weifang, China.
Neurosciences (Riyadh, Saudi Arabia)
|January 12, 2025
概括
这项研究使用WGCNA识别了与帕金森病 (PD) 相关的关键长非编码RNA (lncRNAs),为PD病理生理学和潜在治疗点提供了新的见解.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 帕金森病 (PD) 是一种具有复杂病理生理学的神经退行性疾病.
- 长非编码RNAs (lncRNAs) 在PD中的作用仍然不完全理解.
研究的目的:
- 为了确定与帕金森病相关的关键 lncRNAs.
- 阐明 lncRNAs 在 PD 病理生理学中的作用.
- 为开发PD的基于ncRNA的新型治疗策略提供基础.
主要方法:
- 权重基因共同表达网络分析 (WGCNA) 应用于来自黑体和白细胞的基因表达数据.
- 在PD患者中对差异表达基因 (DEGs) 的分析.
- 基因本体学 (GO) 和基因和基因组的京都百科全书 (KEGG) 路径丰富分析.
主要成果:
- 鉴定了两个重要的 lncRNA 模块,其中青模块在 GSE7621 中至关重要.
- 对GO的分析突出了包括酸盐结合和炎症反应在内的功能.
- 凯格分析显示,P13K-Akt和mTOR等信号通路的丰富.
- 确定了两个关键的lncRNAs,即CH17-189H20.1和RP11-168O16.1,它们被发现.
结论:
- WGCNA有效地确定了PD相关的基因模块和核心 lncRNAs.
- 该研究确定了潜在的目标基因,以便进一步调查.
- 这些发现有助于更深入地了解lncRNA参与PD病变的发生.
相关概念视频
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Genome-wide Association Studies-GWAS
12.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.4K
Parkinson's Disease: Overview
463
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
463
Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K


